Literature DB >> 1655452

Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value.

L C Archard1, N E Bowles, L Cunningham, C A Freeke, E G Olsen, M L Rose, B Meany, H J Why, P J Richardson.   

Abstract

Enteroviruses are well recognized in the aetiology of myocarditis. Molecular hybridization using enterovirus group-specific probes shows that virus can be detected in endomyocardial biopsies and persists in myocardium after the inflammation heals. Virus persistence is associated with the subsequent development of dilated cardiomyopathy, progressing to end-stage disease requiring cardiac transplantation. Infectious virus cannot usually be isolated from myocardium nor can virus-specific antigens be detected after the initial inflammatory stage. Patients with healed myocarditis or dilated cardiomyopathy may have no histological evidence of inflammation despite detection of virus-specific RNA sequences by molecular hybridization. Persisting enterovirus RNA in dilated cardiomyopathy is the strongest known predictor of poor prognosis. The molecular mechanism of virus persistence is the selection of defective virus mutants during the initial phase of disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655452     DOI: 10.1093/eurheartj/12.suppl_d.56

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

Review 1.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Correlations among persistent viral infection, heart function and Chinese medicine syndromes in dilated cardiomyopathy patients.

Authors:  Qiang Liu; Xiao-Jia Su; Yan Yu; Yong-Lin Liu
Journal:  Chin J Integr Med       Date:  2014-07-14       Impact factor: 1.978

3.  [Pathogenesis of inflammatory cardiomyopathies].

Authors:  H P Schultheiss; M Pauschinger; U Kühl
Journal:  Med Klin (Munich)       Date:  1998-04-15

4.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

5.  Coxsackievirus B3 infection and its mutation in Keshan disease.

Authors:  Li-Qun Ren; Xiang-Jun Li; Guang-Sheng Li; Zhi-Tao Zhao; Bo Sun; Fei Sun
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

7.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Successful heart transplantation following neonatal necrotic enterovirus myocarditis.

Authors:  Jacob Simmonds; David Cubitt; Michael Ashworth; Michael Burch
Journal:  Pediatr Cardiol       Date:  2007-12-25       Impact factor: 1.655

9.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction.

Authors:  P J Keeling; S Jeffery; A L Caforio; R Taylor; G F Bottazzo; M J Davies; W J McKenna
Journal:  Br Heart J       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.